{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T01:55:56Z","timestamp":1774403756093,"version":"3.50.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["theclinics.com","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Care Nursing Clinics of North America"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cnc.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T20:41:17Z","timestamp":1707338477000},"page":"295-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding the Evolving Pathophysiology of Coronavirus Disease 2019 and Adult Nursing Management"],"prefix":"10.1016","volume":"36","author":[{"given":"Kathleen M.","family":"Luckner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen A.","family":"Seckel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cnc.2024.01.002_bib1","doi-asserted-by":"crossref","first-page":"103529","DOI":"10.1016\/j.critrevonc.2021.103529","article-title":"COVID-19 and immunothrombosis: pathophysiology and therapeutic implications","volume":"168","author":"Lim","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cnc.2024.01.002_bib2","doi-asserted-by":"crossref","first-page":"631139","DOI":"10.3389\/fimmu.2021.631139","article-title":"A\u00a0comprehensive review of viral characteristics, transmission, pathophysiology, immune response, and management of SARS-CoV-2 and COVID-19 as a basis for controlling the pandemic","volume":"12","author":"Triggle","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.cnc.2024.01.002_bib3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ccc.2021.05.003","article-title":"Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury","volume":"37","author":"Swenson","year":"2021","journal-title":"Crit Care Clin"},{"issue":"2","key":"10.1016\/j.cnc.2024.01.002_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3390\/vaccines11020489","article-title":"Crosstalk between COVID-19 infection and kidney diseases: a review on the metabolomic approaches","volume":"11","author":"Murali","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"5","key":"10.1016\/j.cnc.2024.01.002_bib5","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10096-020-04138-6","article-title":"COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection","volume":"40","author":"Beyerstedt","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.cnc.2024.01.002_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-022-01814-1","article-title":"COVID-19 infection: an overview on cytokine storm and related interventions","volume":"19","author":"Montazersaheb","year":"2022","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.cnc.2024.01.002_bib7","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"23","key":"10.1016\/j.cnc.2024.01.002_bib8","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cnc.2024.01.002_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID-19","volume":"93","author":"Hu","year":"2021","journal-title":"J\u00a0Med Virol"},{"issue":"4","key":"10.1016\/j.cnc.2024.01.002_bib10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1566524021666210408103921","article-title":"COVID-19 and ARDS: update on preventive and therapeutic venues","volume":"22","author":"Narota","year":"2022","journal-title":"Curr Mol Med"},{"issue":"4","key":"10.1016\/j.cnc.2024.01.002_bib11","doi-asserted-by":"crossref","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective","volume":"55","author":"Mason","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cnc.2024.01.002_bib12","doi-asserted-by":"crossref","first-page":"n436","DOI":"10.1136\/bmj.n436","article-title":"Severe covid-19 pneumonia: pathogenesis and clinical management","volume":"372","author":"Attaway","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.cnc.2024.01.002_bib13","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1513\/AnnalsATS.202005-427RL","article-title":"Respiratory mechanics and gas exchange in COVID-19-associated respiratory failure","volume":"17","author":"Schenck","year":"2020","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.cnc.2024.01.002_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","article-title":"Why COVID-19 silent hypoxemia is baffling to physicians","volume":"202","author":"Tobin","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.cnc.2024.01.002_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.17219\/acem\/143542","article-title":"Acute kidney injury in patients with COVID-19: epidemiology, pathogenesis and treatment","volume":"31","author":"Adamczak","year":"2022","journal-title":"Adv Clin Exp Med"},{"issue":"12","key":"10.1016\/j.cnc.2024.01.002_bib16","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/jpm11121328","article-title":"COVID-19 and venous thromboembolism: from pathological mechanisms to clinical management","volume":"11","author":"Zhou","year":"2021","journal-title":"J\u00a0Personalized Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib17","doi-asserted-by":"crossref","first-page":"599334","DOI":"10.3389\/fcvm.2020.599334","article-title":"Thrombosis and coagulopathy in COVID-19: current understanding and implications for antithrombotic treatment in patients treated with percutaneous coronary intervention","volume":"7","author":"Liu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib18","series-title":"Coronavirus disease 2019 (COVID-19) treatment guidelines","year":"2023"},{"issue":"3","key":"10.1016\/j.cnc.2024.01.002_bib19","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1097\/CCM.0000000000004899","article-title":"Surviving Sepsis Campaign guidelines on the management of adults with coronavirus disease 2019 (COVID-19) in the ICU: first update","volume":"49","author":"Alhazzani","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib20","series-title":"Infectious Diseases Society of America guidelines on the treatment and management of patients with COVID-19","author":"Bhimraj","year":"2023"},{"key":"10.1016\/j.cnc.2024.01.002_bib21","unstructured":"World Health Organization. Clinical management of COVID-19: living guideline. 2023. Available at: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2023.2. Accessed August 21, 2023."},{"issue":"7","key":"10.1016\/j.cnc.2024.01.002_bib22","doi-asserted-by":"crossref","first-page":"e0000561","DOI":"10.1371\/journal.pgph.0000561","article-title":"Definitions matter: heterogenity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis","volume":"2","author":"Guerin","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.cnc.2024.01.002_bib23","unstructured":"U.S. Food & Drug Administration. Emergency use authorization. 2023. Available at Emergency Use Authorization | FDA. Accessed September 2, 2023."},{"key":"10.1016\/j.cnc.2024.01.002_bib24","unstructured":"U.S. Food & Drug Administration. FAQs: What happens to EUAs when a public health emergency ends. 2023. . Available at FAQs: What happens to EUAs when a public health emergency ends? | FDA. Accessed September 2, 2023."},{"key":"10.1016\/j.cnc.2024.01.002_bib25","unstructured":"Phizer Laboratories. Highlights of prescribing information: Paxlovid. 2023. Available at labeling.pfizer.com\/ShowLabeling.aspx?id=19599. Accessed August 21, 2023."},{"key":"10.1016\/j.cnc.2024.01.002_bib26","series-title":"Food and drug administration","article-title":"Coronavirus (COVID-19) drugs","year":"2023"},{"key":"10.1016\/j.cnc.2024.01.002_bib27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib28","unstructured":"Gilead. Highlights of prescribing information: Veklury. 2023. Available at veklury_pi.pdf (gilead.com). Accessed August 21, 2023."},{"key":"10.1016\/j.cnc.2024.01.002_bib29","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for treatment of COVID-19 \u2013 final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.cnc.2024.01.002_bib30","doi-asserted-by":"crossref","first-page":"e2244505","DOI":"10.1001\/jamanetworkopen.2022.44505","article-title":"Association of remdesivir treatment with mortality among hospitalized adults with COVID-19 in the United States","volume":"5","author":"Chokkalingam","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cnc.2024.01.002_bib31","unstructured":"Merck. Fact sheet for healthcare providers: emergency use authorization for lagevrio\u2122 (molnupiravir) capsules. 2023. Available at molnupiravir-hcp-fact-sheet.pdf (merck.com). Accessed August 21, 2023."},{"key":"10.1016\/j.cnc.2024.01.002_bib32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients","volume":"386","author":"Bernal","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"10373","key":"10.1016\/j.cnc.2024.01.002_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care aloe as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomized controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cnc.2024.01.002_bib34","article-title":"Recommendations for investigational COVID-19 convalescent plasma","year":"2022","journal-title":"Food and Drug Administration"},{"issue":"17","key":"10.1016\/j.cnc.2024.01.002_bib35","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jama.2021.18178","article-title":"Effect of convalescent plasma on organ support-free days in critically ill patients with COVID-19: a randomized clinical trial","volume":"326","author":"Writing Committee for the REMAP-CAP Investigators","year":"2021","journal-title":"JAMA"},{"issue":"10289","key":"10.1016\/j.cnc.2024.01.002_bib36","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(21)00897-7","article-title":"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial","volume":"397","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.cnc.2024.01.002_bib37","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/s41591-021-01488-2","article-title":"Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial","volume":"27","author":"Begin","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib38","series-title":"StatPearls: corticosteroids","author":"Hodgens","year":"2023"},{"key":"10.1016\/j.cnc.2024.01.002_bib39","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.cnc.2024.01.002_bib40","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1001\/jama.2020.16761","article-title":"Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial","volume":"324","author":"Dequin","year":"2020","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.cnc.2024.01.002_bib41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2020.17022","article-title":"Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial","volume":"324","author":"Angus","year":"2020","journal-title":"JAMA"},{"issue":"7\u20138","key":"10.1016\/j.cnc.2024.01.002_bib42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00508-020-01805-8","article-title":"Methylprednisolone in adults hospitalized with COVID-19 pneumonia: an open-label randomized trial (GLUCOCOVID)","volume":"133","author":"Corral-Gudino","year":"2021","journal-title":"Wien Klin Wochenschr [Central J Euro Med]"},{"issue":"2","key":"10.1016\/j.cnc.2024.01.002_bib43","first-page":"116","article-title":"Early use of corticosteroid may prolong SARS-CoV-2 shedding in non-intensive care unit patients with COVID-19 pneumonia: a multicenter, single-blind","volume":"100","author":"Tang","year":"2021","journal-title":"randomized control trial Respiration"},{"key":"10.1016\/j.cnc.2024.01.002_bib44","doi-asserted-by":"crossref","first-page":"825749","DOI":"10.3389\/fphar.2022.825749","article-title":"Tocilizumab and COVID-19: timing of administration and efficacy","volume":"13","author":"Abidi","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.cnc.2024.01.002_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2030340","article-title":"Tocilizumab in patients hospitalized with Covid-19 pneumonia","volume":"384","author":"Salamar","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib46","unstructured":"Genentech. Highlights of prescribing information: Actemra. 2022. Available at: actemra_prescribing.pdf (gene.com). Accessed August 21, 2023."},{"issue":"9","key":"10.1016\/j.cnc.2024.01.002_bib47","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2031994","article-title":"Baricitinib plus remdesivir for hospitalized adults with COVID-19","volume":"384","author":"Kalil","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10302","key":"10.1016\/j.cnc.2024.01.002_bib48","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(21)00438-4","article-title":"Current and future status of JAK inhibitors","volume":"398","author":"McLornan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cnc.2024.01.002_bib49","unstructured":"Eli Lilly and Company. Olumiant, baricitinib tablet, film coated. Update May 2022. Available at: These highlights do not include all the information needed to use OLUMIANT safely and effectively. See full prescribing information for OLUMIANT.OLUMIANT (baricitinib) tablets, for oral useInitial U.S. Approval: 2018 (lilly.com). Accessed August 21, 2023."},{"issue":"12","key":"10.1016\/j.cnc.2024.01.002_bib50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","article-title":"Anit-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomized, placebo-controlled, phase 3 trial","volume":"10","author":"Vlaar","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib51","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/S2665-9913(20)30341-6","article-title":"Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomized controlled trial","volume":"2","author":"Vlaar","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.cnc.2024.01.002_bib52","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jama.2023.11043","article-title":"Abatacept, Cenicriviroc, or Infliximab for treatment of adults hospitalized with COVID-19 pneumonia","volume":"330","author":"O\u2019Halloran","year":"2023","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cnc.2024.01.002_bib53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with COVID-19 pneumonia","volume":"385","author":"Guimaraes","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.cnc.2024.01.002_bib54","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with covid-19","volume":"384","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.cnc.2024.01.002_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2022.23257","article-title":"Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial","volume":"339","author":"Writing Committee for the REMAP-CAP Investigators","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.cnc.2024.01.002_bib56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib57","series-title":"AACN procedure manual for high acuity, progressive, and critical care","first-page":"135","article-title":"Oxygen saturation monitoring with pulse oximetry","author":"Lucas","year":"2023"},{"issue":"25","key":"10.1016\/j.cnc.2024.01.002_bib58","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMc2029240","article-title":"Racial bias in pulse oximetry measurement","volume":"383","author":"Sjoding","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.cnc.2024.01.002_bib59","doi-asserted-by":"crossref","first-page":"22330856","DOI":"10.1001\/jamanetworkopen.2023.30856","article-title":"Clinical outcomes associated with overestimation of oxygen saturation in pulse oximetry in patients hospitalized with COVID-19","volume":"6","author":"Fawzy","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.cnc.2024.01.002_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ajem.2017.07.083","volume":"36","author":"Ni","year":"2018","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib61","doi-asserted-by":"crossref","first-page":"1068327","DOI":"10.3389\/fmed.2022.1068327","article-title":"High-flow nasal oxygen in acute hypoxemic respiratory failure: a narrative review of the evidence before and after the COVID-19 pandemic","volume":"9","author":"Genecand","year":"2022","journal-title":"Front Med"},{"issue":"6","key":"10.1016\/j.cnc.2024.01.002_bib62","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamainternmed.2022.1070","article-title":"Assessment of awake prone positioning in hospitalized adults with COVID-19","volume":"182","author":"Tian","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib63","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(22)00043-1","article-title":"Aware prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis","volume":"10","author":"Li","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib64","doi-asserted-by":"crossref","first-page":"e071966","DOI":"10.1136\/bmj-2022-071966","article-title":"Efficacy of awake prone positioning in patients with covid-19 related hypoxemic respiratory failure: systematic review and meta-analysis","volume":"379","author":"Weatherald","year":"2022","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.cnc.2024.01.002_bib65","doi-asserted-by":"crossref","first-page":"S472","DOI":"10.1097\/01.ccm.0000909560.54344.b2","article-title":"Awake prone positioning for patients with COVID-19 and acute respiratory failure: a meta-analysis","volume":"51","author":"Siddiqui","year":"2023","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.cnc.2024.01.002_bib66","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/CCM.0000000000005915","article-title":"Mechanical power delivered by noninvaive ventilation contributes to physio-anatomical and clinical responses to early versus late proning in COVID-19 pneumonia","volume":"51","author":"Musso","year":"2023","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib67","first-page":"926","article-title":"Awake prone positioining for non-intubated COVID-19 patients with acute respiratory failure: a meta-analysis of randomised controlled trials","volume":"12","author":"Cheema","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"12","key":"10.1016\/j.cnc.2024.01.002_bib68","doi-asserted-by":"crossref","first-page":"e0805","DOI":"10.1097\/CCE.0000000000000805","article-title":"Physiologic effects of the awake prone position combined with high-flow nasal oxygen on gas exchange and work of breathing in patient with severe COVID-19 pneumonia: a randomized crossover trial","volume":"4","author":"Lehnigue","year":"2022","journal-title":"Crit Care Explor"},{"issue":"4","key":"10.1016\/j.cnc.2024.01.002_bib69","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4037\/ccn2021719","article-title":"Awake self-prone positioning and the evidence","volume":"41","author":"Seckel","year":"2021","journal-title":"Crit Care Nurse"},{"issue":"5","key":"10.1016\/j.cnc.2024.01.002_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4037\/ccn2021153","article-title":"Awake self-prone positioning: implementation during the COVID-19 pandemic","volume":"41","author":"Allicock","year":"2021","journal-title":"Crit Care Nurse"},{"key":"10.1016\/j.cnc.2024.01.002_bib71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib72","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Guerrin","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.cnc.2024.01.002_bib73","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An official American Thoracic Society\/European Society of Intensive Care Medicine\/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome","volume":"195","author":"Fan","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cnc.2024.01.002_bib74","doi-asserted-by":"crossref","first-page":"103088","DOI":"10.1016\/j.iccn.2021.103088","article-title":"Complications of prone positioning in patients with COVID-19: a cross sectional study","volume":"67","author":"Binda","year":"2021","journal-title":"Intensive Crit Care Nurs"},{"issue":"4","key":"10.1016\/j.cnc.2024.01.002_bib75","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jopan.2020.05.008","article-title":"Prone position of patients with COVID-19 and acute respiratory distress syndrome","volume":"35","author":"Makic","year":"2020","journal-title":"J\u00a0Perianesth Nurs"},{"issue":"6","key":"10.1016\/j.cnc.2024.01.002_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4037\/ccn2021900","article-title":"An evidence-based protocol for manual prone positioning of patients with ARDS","volume":"41","author":"Ryan","year":"2021","journal-title":"Crit Care Nurse"},{"issue":"1","key":"10.1016\/j.cnc.2024.01.002_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4037\/ccn2023174","article-title":"Manual prone positioning in adults: reducing the risk of harm through evidence-based practices","volume":"43","author":"Morata","year":"2023","journal-title":"Crit Care Nurse"},{"key":"10.1016\/j.cnc.2024.01.002_bib78","series-title":"AACN procedure manual for high acuity, progressive, and critical care","first-page":"143","article-title":"Prone positioning for acute respiratory distress syndrome patients","author":"Vollman","year":"2023"},{"key":"10.1016\/j.cnc.2024.01.002_bib79","series-title":"AACN procedure manual for high acuity, progressive, and critical care","first-page":"122","article-title":"Extracorporeal membrane oxygenation","author":"Moutray","year":"2023"},{"key":"10.1016\/j.cnc.2024.01.002_bib80","unstructured":"ELSO COVID-19 Working Group. Extracorporeal life support organization COVID-19 interim guidelines. April 12, 2000. Available at: https:\/\/www.elso.org\/portals\/0\/files\/pdf\/elso%20covid%20guidelines%20final.pdf. Accessed October 19, 2023."},{"issue":"6","key":"10.1016\/j.cnc.2024.01.002_bib81","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MAT.0000000000001432","article-title":"Management of adult patients supported with venovenous extracorporeal membrane oxygenation (VV ECMO): guideline from the extracorporeal life support organization (ELSO)","volume":"67","author":"Tonna","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.cnc.2024.01.002_bib82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S2213-2600(22)00403-9","article-title":"In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroEMCO-COVID): a multicentre, prospective observational study","volume":"11","author":"Lorusso","year":"2023","journal-title":"Lancet Resp Med"}],"container-title":["Critical Care Nursing Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899588524000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899588524000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T22:57:58Z","timestamp":1722034678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899588524000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0899588524000029"],"URL":"https:\/\/doi.org\/10.1016\/j.cnc.2024.01.002","relation":{},"ISSN":["0899-5885"],"issn-type":[{"value":"0899-5885","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the Evolving Pathophysiology of Coronavirus Disease 2019 and Adult Nursing Management","name":"articletitle","label":"Article Title"},{"value":"Critical Care Nursing Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnc.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}